Literature DB >> 20815113

Mechanism of dissociation of human apolipoproteins A-I, A-11, and C from complexes with dimyristoylphosphatidylcholine as studied by thermal denaturation.

D J Reijngoud, M C Phillips.   

Abstract

The effect of temperature on the structure of human apolipoprotein A-I (apo A-I), apo A-11, and the combined apo C fraction in the absence and presence of dimyristoylphosphatidylcholine(DMPC) has been investigated.The thermal denaturation of the apolipoproteins was monitored by circular dichroism spectroscopy. In the absence of lipid,the apolipoproteins A-I and A-I1 denature over a wide temperature range, giving van't Hoff enthalpies of 33 +/- 4 kcal/mol of apo A-I and 17.8 +/- 0.2 kcal/mol of apo A-11. These enthalpies are independent of the protein concentration, although a decrease in molar ellipticity was observed on increasing the protein concentration from 0.01 to 1 mg/mL. No effect of temperature could be observed on the combined apoC fraction because at 0.01 and 1 mg/mL the apo C's were essentially random coiled. In the presence of DMPC, thermal denaturation could be measured for apo A-I above 70-75 "C and for apo A-I1 and apo C above about 45 OC. In general,the denaturations were biphasic reactions for all apolipoproteins tested, with only a third, minor intermediate phase for apo A-I/DMPC denaturation. The two major kinetic phases are identified as an unfolding reaction of the apolipoprotein bound to the complex followed by a desorption step.The relaxation times (tau) associated with the latter step are dependent on the molecular weight of the apoprotein: when the temperature is increased from 70 to 90 OC, tau decreases from 400 to 1 min for apo A-I, while for apo A-I1 and apoC as the temperature is increased from 50 to 70 OC, tau decreases from 15 to l min. The activation energies for the desorption of apoprotein decrease with decreasing molecular weight: the values are 71 +/- 2 kcal/mol of apo A-I, 28 +/- 3 kcal/mol of apo A-11, and 22 +/- 3 kcal/mol of apo C. The thermal denaturation of apo A-I/DMPC is a thermodynamically irreversible process whereas the denaturations of apoA-II/DMPC and apo C/DMPC complexes are reversible with midpoints of 71 and 54 "C, respectively. The van't Hoff enthalpies are 16.8 +/- 0.6 kcal/mol of apo A-I1 (T < 70 "C),86 +/- 2 kcal/mol of apo A-I1 (T > 70 "C), and 22.3 +/- 0.8 kcal/mol of apo C. On the basis of the above findings, a model to describe the association and dissociation of apolipoproteins with DMPC has been derived. It is assumed that, on a molecular level, the association reaction is determined by two parameters: (1) the intrinsic rate constant describing the insertion of an apolipoprotein into a "vacancy" in the phospholipid matrix ("on rate") and (2) the probability of the colliding apoprotein molecule encountering a vacancy in the phospholipid bilayer. Alterations in either of these two parameters change the macroscopic rate constant of association.Desorption ("off rate") involves the protein leaving from a constant phospholipid environment because the perturbed adjacent lipid molecules render this process insensitive to the physical state of the remainder of the bilayer. The similarities in the van't Hoff enthalpies associated with the reversible desorption of apo A-I1 and apo C to literature values for the calorimetric enthalpies of association of these proteins with DMPC suggest that the desorption is a two-state process.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 20815113     DOI: 10.1021/bi00299a022

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  9 in total

1.  Structure and stability of apolipoprotein a-I in solution and in discoidal high-density lipoprotein probed by double charge ablation and deletion mutation.

Authors:  Irina N Gorshkova; Tong Liu; Horng-Yuan Kan; Angeliki Chroni; Vassilis I Zannis; David Atkinson
Journal:  Biochemistry       Date:  2006-01-31       Impact factor: 3.162

2.  Spontaneous remodeling of HDL particles at acidic pH enhances their capacity to induce cholesterol efflux from human macrophage foam cells.

Authors:  Su Duy Nguyen; Katariina Öörni; Miriam Lee-Rueckert; Tero Pihlajamaa; Jari Metso; Matti Jauhiainen; Petri T Kovanen
Journal:  J Lipid Res       Date:  2012-08-01       Impact factor: 5.922

3.  Hot spots in apolipoprotein A-II misfolding and amyloidosis in mice and men.

Authors:  Olga Gursky
Journal:  FEBS Lett       Date:  2014-02-20       Impact factor: 4.124

4.  Role of apolipoprotein A-II in the structure and remodeling of human high-density lipoprotein (HDL): protein conformational ensemble on HDL.

Authors:  Xuan Gao; Shujun Yuan; Shobini Jayaraman; Olga Gursky
Journal:  Biochemistry       Date:  2012-06-01       Impact factor: 3.162

5.  Differential stability of high-density lipoprotein subclasses: effects of particle size and protein composition.

Authors:  Xuan Gao; Shujun Yuan; Shobini Jayaraman; Olga Gursky
Journal:  J Mol Biol       Date:  2009-02-21       Impact factor: 5.469

6.  Apolipoprotein modulation of streptococcal serum opacity factor activity against human plasma high-density lipoproteins.

Authors:  Corina Rosales; Baiba K Gillard; Harry S Courtney; Francisco Blanco-Vaca; Henry J Pownall
Journal:  Biochemistry       Date:  2009-08-25       Impact factor: 3.162

7.  Serum opacity factor unmasks human plasma high-density lipoprotein instability via selective delipidation and apolipoprotein A-I desorption.

Authors:  Baiba K Gillard; Harry S Courtney; John B Massey; Henry J Pownall
Journal:  Biochemistry       Date:  2007-10-17       Impact factor: 3.162

8.  Properties of the products formed by the activity of serum opacity factor against human plasma high-density lipoproteins.

Authors:  Henry J Pownall; Harry S Courtney; Baiba K Gillard; John B Massey
Journal:  Chem Phys Lipids       Date:  2008-09-16       Impact factor: 3.329

9.  Role of secondary structure in protein-phospholipid surface interactions: reconstitution and denaturation of apolipoprotein C-I:DMPC complexes.

Authors:  Sangeeta Benjwal; Shobini Jayaraman; Olga Gursky
Journal:  Biochemistry       Date:  2007-03-07       Impact factor: 3.162

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.